Get the Stockscreener App
4.395
5.50%
-0.245
Goodrx Holdings Inc stock is traded at $4.395, with a volume of 6.47M.
It is down -5.50% in the last 24 hours and up +6.43% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$4.64
Open:
$4.66
24h Volume:
6.47M
Relative Volume:
1.58
Market Cap:
$432.78M
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
-33.14
EPS:
-0.1326
Net Cash Flow:
$64.06M
1W Performance:
-3.20%
1M Performance:
+6.43%
6M Performance:
+1.50%
1Y Performance:
-36.26%
1-Day Range:
$4.37
$4.72
1-Week Range:
$4.26
$5.8099
52-Week Range:
$3.305
$7.11
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
4.3901 | 1.61B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
286.94 | 48.92B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
95.57 | 17.25B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.94 | 13.59B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
90.55 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.94 | 7.14B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-09-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-23-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-16-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
Will GoodRx Holdings Inc. stock recover after recent dropMarket Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Price action breakdown for GoodRx Holdings Inc.Quarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
What technical models suggest about GoodRx Holdings Inc.’s comebackPortfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
GoodRx’s Stock Soars: What’s Behind the Uptick? - timothysykes.com
BofA Securities maintains Underperform rating on GoodRx stock amid TrumpRx uncertainty - Investing.com
GoodRx (GDRX) Faces Uncertain Impact from Potential TrumpRx Coll - GuruFocus
Trump Administration Engages Pharmacies, GoodRx For TrumpRx LaunchGoodRx Holdings (NASDAQ:GDRX) - Benzinga
BofA on GoodRx Holdings Inc. (GDRX): 'We don’t have a strong view at this time on the potential upside/downside from TrumpRx' - StreetInsider
GoodRx (GDRX) Shares Surge as Talks with White House Progress - GuruFocus
GoodRx: Game-Changer Partnerships on the Horizon? - StocksToTrade
GoodRx stock spikes on plans to join TrumpRx (GDRX:NASDAQ) - Seeking Alpha
Candlestick signals on GoodRx Holdings Inc. stock todayBull Run & Growth-Oriented Investment Plans - newser.com
What machine learning models say about GoodRx Holdings Inc.Portfolio Value Summary & Accurate Buy Signal Alerts - newser.com
GoodRx Holdings Inc Stock Analysis and ForecastSmall Cap Stock Opportunities & Big Profit Small Capital - earlytimes.in
GoodRx (NASDAQ:GDRX) Earns Hold (C-) Rating from Weiss Ratings - MarketBeat
GoodRx Holdings, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo
GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call - The Joplin Globe
News - FinancialContent
GoodRx (GDRX) Faces Industry Changes Amid BlinkRx Developments - GuruFocus
Q2 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks - The Globe and Mail
GoodRx (GDRX) Cuts Cost of Repatha to Boost Patient Savings - GuruFocus
GoodRx expands affordable access to Repatha® with nearly 60% savings - MarketScreener
Can trapped investors hope for a rebound in GoodRx Holdings Inc.Market Growth Review & Capital Protection Trade Alerts - newser.com
$239 cash price for Repatha — GoodRx expands access with nearly 60% savings at 70,000+ pharmacies - Stock Titan
Can you recover from losses in GoodRx Holdings Inc.Portfolio Performance Report & Long-Term Capital Growth Strategies - newser.com
Is GoodRx Holdings Inc. stock entering bullish territoryShare Buyback & Safe Entry Point Alerts - newser.com
GoodRx Holdings Inc. (GDRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
GoodRx (GDRX): Evaluating the Stock’s Valuation After Recent Share Price Volatility - Yahoo Finance
How to recover losses in GoodRx Holdings Inc. stockWeekly Stock Summary & Entry Point Confirmation Signals - newser.com
What’s the recovery path for long term holders of GoodRx Holdings Inc.Quarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com
Is GoodRx Holdings Inc. stock a buy for dividend growthPrice Action & Weekly Market Pulse Alerts - newser.com
GoodRx Target of Unusually High Options Trading (NASDAQ:GDRX) - MarketBeat
Should You Think About Buying GoodRx Holdings, Inc. (NASDAQ:GDRX) Now? - simplywall.st
What analysts say about GoodRx Holdings Inc stockStock Buyback Announcements & Low Risk Capital Appreciation - earlytimes.in
GoodRx stock surges on potential TrumpRx partnership and Kroger expansion - Investing.com
GoodRx (GDRX) Stock Climbs as Citi Reaffirms Buy Rating - GuruFocus
GoodRx (GDRX) Shares Surge 19% After CEO's Comments - GuruFocus
GoodRx (GDRX) Shares Rise on Potential Inclusion in TrumpRx Init - GuruFocus
GoodRx gains with late session surge on CEO remarks; closes up 19% - Seeking Alpha
GoodRx stock soars after CEO hints at potential TrumpRx partnership By Investing.com - Investing.com Canada
GoodRx Holdings, Inc. (GDRX) Spikes After CEO Discusses Trump Conversations - StreetInsider
GoodRx expands tie-up with Kroger to offer branded drugs at discounted price - Reuters
Major Pharmacy Breakthrough: GoodRx Brings Instant Brand Drug Savings to 2,200 Kroger Stores in 35 States - Stock Titan
Wall Street Has a Mixed Opinion on GoodRx Holdings (GDRX) - MSN
GoodRx Holdings, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Pressures - Markets Mojo
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.29%
1.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):